Early Neuroaxonal Damage in Neurologic Disorders Associated With GAD65 Antibodies.
Katharina EisenhutJennifer FaberDaniel EngelsRamona GerhardsJan LewerenzKathrin DopplerClaudia SommerRobert MarkewitzKim K FalkRosa RösslingHarald PruessCarsten FinkeJonathan WickelChristian GeisDominica RatusznyLena K PfefferStefan BittnerJohannes PiepgrasAndrea KraftJaqueline KlausewitzBrigitte NuscherTania KümpfelFranziska S Thalernull nullPublished in: Neurology(R) neuroimmunology & neuroinflammation (2023)
Together, our data provide evidence for early neuroaxonal damage and support the need for timely therapeutic interventions in GAD65 antibody-associated neurologic disorders.